Notice to Extend the Expiration Date of PAR-20-255: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Notice Number:
NOT-HG-23-037

Key Dates

Release Date:

April 20,2023

Related Announcements

  • July 29, 2020 - Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional). See NOFO PAR-20-255.
  • April 20, 2023 - Notice to Extend the Expiration Date of PAR-20-254: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional). See Notice NOT-HG-23-036.
  • April 20, 2023 - Notice to Extend the Expiration Date of PAR-20-257: Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional). See Notice NOT-HG-23-038.

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this notice is to extend the expiration date for PAR-20-255 - PAR-20-255: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) by one review cycle..

An additional receipt date has been added, October 19, 2023, for new applications and November 17, 2023, for resubmission and revision applications. This Notice of Funding Opportunity now expires on November 18, 2023. The changes below are in bold italics.

The Notice of Funding Opportunity currently reads as:

Part 1. Overview Information, Key Dates

Application Due Date(s):

New Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023

Resubmission and Revision Due Dates: November 17, 2020, March 17, 2021, July 19, 2021, November 17, 2021, March 17, 2022, July 19, 2022, November 17, 2022, March 17, 2023, July 19, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Applications: Not Allowed

Scientific Merit Review: Standard dates apply

Advisory Council Review: Standard dates apply

Earliest Start Date: Standard dates apply

Expiration Date: July 20, 2023

The Notice of Funding Opportunity has been modified as follows:

Part 1. Overview Information, Key Dates

Application Due Date(s):

New Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023, October 19, 2023

Resubmission and Revision Due Dates: November 17, 2020, March 17, 2021, July 19, 2021, November 17, 2021, March 17, 2022, July 19, 2022, November 17, 2022, March 17, 2023, July 19, 2023, November 17, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Applications: Not Allowed

Scientific Merit Review: Standard dates apply

Advisory Council Review: Standard dates apply

Earliest Start Date: Standard dates apply

Expiration Date: November 18, 2023

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Dave Kaufman, Ph.D
National Human Genome Research Institute (NHGRI)
Telephone: 301-594-6907
Email: dave.kaufman@nih.gov